Post-translational modifications (PTMs) are a major feature of TDP-43 pathology in ALS and FTD, and likely play diverse roles in TDP-43 dysfunction, aggregation propensity, and neurotoxicity. Here, TARDBP is linked to amyotrophic lateral sclerosis.